Lewis Kaufman is a Nephrology physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 34 publications with 1,246 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5 East 98th Street
Mount Sinai Hospital Nephrology
New York, NY 10029
Telephone
212-241-4060Registry record last updated 8 Jul 2007.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- W. L. Gore & Associates, Inc.Program year20252 payments
- Fresenius USA Marketing, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
24.8%Solutions for parenteral nutrition17.5%Calcium Acetate100%Part D≥14 patientsFactor Xa inhibitor4.2%Eliquis100%Part D<11 patients+ 1 more class in this area
Other
23.1%Phosphate Binder15.6%Sevelamer Carbonate100%Part D≥13 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia7.5%Velphoro100%Part D<11 patientsCardiovascular
21.4%Beta blocker10%Carvedilol69%Labetalol Hcl31%Part D<11 patientsCalcium channel blocker4.7%Nifedipine Er100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
- Podocyte-to-parietal epithelial cell signal by exosomes drives proliferative glomerulopathy
Icahn School of Medicine at Mount Sinai
FY2026$816,825R01DK147153 - Podocyte-specific Rap1 agonism for treatment of glomerular disease
Icahn School of Medicine at Mount Sinai
FY2026$618,264R01DK129735 - Podocyte-specific Rap1 agonism for treatment of glomerular disease
Icahn School of Medicine at Mount Sinai
FY2025$618,264R01DK129735
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rapid Podocyte Loss Triggers Formation of Intercellular Bridges
Journal of the American Society of Nephrology
2024 - Transcriptome-wide association analysis identifies DACH1 as a kidney disease risk gene that contributes to fibrosis
Journal of Clinical Investigation
2021 - DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity
Journal of Clinical Investigation
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”